Prospective comprehensive profiling of immune responses to COVID‐19 vaccination in patients on zanubrutinib therapy

Zanubrutinib‐treated and treatment‐naïve patients with chronic lymphocytic leukaemia (CLL) or Waldenstrom's macroglobulinaemia were recruited in this prospective study to comprehensively profile humoral and cellular immune responses to COVID‐19 vaccination. Overall, 45 patients (median 72 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi H. O., Lim, Chhay, Lasica, Masa, Whitechurch, Ashley, Tennakoon, Surekha, Saunders, Natalie R., Allen, Lilith F., Rowntree, Louise C., Chua, Brendon Y., Kedzierski, Lukasz, Tan, Hyon‐Xhi, Wheatley, Adam K., Kent, Stephen J., Karapanagiotidis, Theo, Nicholson, Suellen, Williamson, Deborah A., Slavin, Monica A., Tam, Constantine S., Kedzierska, Katherine, Teh, Benjamin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928803/
https://www.ncbi.nlm.nih.gov/pubmed/36819189
http://dx.doi.org/10.1002/jha2.639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928803/
https://www.ncbi.nlm.nih.gov/pubmed/36819189
http://dx.doi.org/10.1002/jha2.639

Ejemplares similares